New studies suggest elevated risk of gastrointestinal cancers in diabetic patients

NewsGuard 100/100 Score

There are minimal data assessing the relationship between diabetes with gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM).

A research article published on November 14, 2009 in the World Journal of Gastroenterology addresses this question. The research team, lead by Dr. Jamal at the Veterans Affairs Medical Center, Long Beach, California, performed a retrospective search of type 2 DM patients matched to non-diabetic controls, discharged from Department of Veterans Affairs hospitals from 1990 to 2000, for the presence of gallbladder, biliary and pancreatic cancer. The database search identified 1 172 496 cases and control subjects for analysis. There was no difference in mean age between the case and control groups. Among patients with type 2 DM, the incidence of pancreatic cancer was increased threefold compared to controls, and gallbladder and extrahepatic biliary cancers were increased by twofold compared to controls.

This is the first study to provide a comprehensive assessment of the risk for gallbladder, biliary and pancreatic cancers in a large cohort of patients with type 2 DM. This study suggests future avenues for investigation to determine preventive measures and screening implementation strategies, to limit the impact of these tumors in the veteran as well as general type 2 DM population in the United States.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals avocado may lower diabetes risk in women, not men